Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.05M | 141.70K | 310.80K | 363.40K | 29.70K |
| Total Receivables | 112.10K | 138.50K | 156.60K | 225.90K | 291.00K |
| Inventory | 238.40K | 252.30K | 262.00K | 148.50K | 7.50K |
| Prepaid Expenses | 50.90K | 23.30K | 43.80K | 24.80K | 173.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.45M | 555.90K | 773.20K | 762.70K | 502.20K |
|
|
|||||
| Total Current Assets | 1.45M | 555.90K | 773.20K | 762.70K | 502.20K |
| Net Property, Plant & Equipment | -- | -- | 300.00 | 600.00 | 900.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.26M | 1.32M | 1.37M | 1.34M | 1.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.71M | 1.88M | 2.15M | 2.10M | 1.83M |
|
|
|||||
| Total Accounts Payable | 252.80K | 185.40K | 385.10K | 378.80K | 493.20K |
| Total Accrued Expenses | 6.30K | 17.60K | 23.10K | 14.70K | 51.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 303.80K | 314.40K | 271.20K | 254.10K | 294.00K |
| Total Other Current Liabilities | 303.80K | 314.40K | 271.20K | 254.10K | 294.00K |
| Total Current Liabilities | 562.80K | 517.40K | 679.40K | 647.60K | 838.60K |
|
|
|||||
| Total Current Liabilities | 562.80K | 517.40K | 679.40K | 647.60K | 838.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | -- | -- |
| Total Liabilities | 562.80K | 517.40K | 679.40K | 647.60K | 838.60K |
|
|
|||||
| Common Stock & APIC | 5.62M | 4.97M | 4.86M | 4.73M | 4.17M |
| Retained Earnings | -4.33M | -3.88M | -3.67M | -3.47M | -3.18M |
| Treasury Stock & Other | 850.90K | 271.60K | 282.00K | 194.70K | -- |
| Total Common Equity | 2.14M | 1.36M | 1.47M | 1.46M | 989.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.14M | 1.36M | 1.47M | 1.46M | 989.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.14M | 1.36M | 1.47M | 1.46M | 989.40K |
|
|
|||||